Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States

Neurogastroenterol Motil. 2024 Nov;36(11):e14903. doi: 10.1111/nmo.14903. Epub 2024 Sep 2.

Abstract

Background: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction characterized by abdominal pain and altered bowel habits, with patient-perceived dissatisfaction of treatment symptom control. We assessed disease burden, satisfaction with medication use, and impact on activities, in participants with IBS with constipation (IBS-C) and diarrhea (IBS-D).

Methods: This study assessed data from a large, United States survey of adults querying demographics, comorbid conditions, quality of life, medication use, satisfaction with symptom control, and work productivity. Participants were grouped into the IBS-C or IBS-D cohort if they met Rome IV criteria, with controls matched 1:1 according to age, sex, race, region, and Charlson Comorbidity Index score. All data were self-reported.

Key results: Nine hundred and ten participants with IBS-C and 669 with IBS-D were matched to controls. The most reported symptoms were abdominal discomfort for IBS-C and abdominal pain and abdominal discomfort for IBS-D. Among the IBS-C and IBS-D cohorts, 74.2% and 65.9%, respectively, took prescription and/or over-the-counter medication for their symptoms. Respondents were more dissatisfied than satisfied with control of their symptoms. Respondents taking prescription medication(s) with or without over-the-counter medication(s) reported better symptom control than respondents only taking over-the-counter medications (p < 0.001). There was significantly higher mean presenteeism, work productivity loss, and daily activity impairment (p < 0.001 for all) in respondents with IBS compared with controls.

Conclusions and inferences: This study provides insight into respondents' experiences of IBS symptoms, including the impact on daily activity, as well as satisfaction with control of symptoms and prescription and over-the-counter medications.

Keywords: abdominal pain; constipation; diarrhea; functional GI diseases; irritable bowel syndrome (IBS).

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Constipation / drug therapy
  • Constipation / psychology
  • Cost of Illness*
  • Diarrhea
  • Female
  • Humans
  • Irritable Bowel Syndrome* / drug therapy
  • Irritable Bowel Syndrome* / psychology
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Quality of Life
  • United States
  • Young Adult